Fundraising Fox
/Companies
Sign in

Agragene

San Diego, US · Founded 2017 · Delaware corporation · 4 known investors

Find your way into Agragene

Sign up to see every warm intro you have to Agragene

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Agragene team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Agragene develops Precision-Guided Sterile Insect Technology (pgSIT) marketed as KNOCKOUT™, a biocontrol product for controlling crop insect pests such as Spotted Wing Drosophila while reducing reliance on traditional insecticides. It serves agricultural growers of berries and cherries in the US and Canada, working alongside integrated pest management programs.

AgTechBiotechClimate Tech

Founders & leadership

BWBryan Witherbee
Bryan WitherbeePresident and CEOHe has more than 25 years in life sciences and agricultural biotechnology, including 15 years at major pharmaceutical companies and prior roles at BD Genomics (genetic testing systems), Adarza BioSystems (label-free detection assays), and Monsanto (molecular biology and genomics technology evaluation), with expertise in biochemistry, assay development, and automation.
TE
Tracy EllisNamed on SEC filing
CS
Clyde ShoresNamed on SEC filing
RS
Robert SchmidtNamed on SEC filing
GA
Gordon AltonNamed on SEC filing
DW
David WebbNamed on SEC filing

Board

CCCarl Casale
Carl CasaleBoard directorOperating Partner – Agriculture at Ospraie Ag Science

Investors · 4

Ospraie Ag Sciencelisted by Ospraie Ag ScienceRye

How we know: funding news · biospace.com · Not right? Tell us

BioGenerator VenturesreportedSt. Louis · $50K – $250K

How we know: igrownews.com · Not right? Tell us

Also in the syndicate · 1

OAS

Funding

SEC filings, press & company announcements

$3.4M disclosed across 3 of 5 rounds · 2020–2023

▶$145KraisedFeb 2021 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Tracy EllisExecutive Officer
  • Robert SchmidtDirector
  • David WebbDirector
  • Carl CasaleDirector
  • Gordon AltonExecutive Officer, Director
  • Clyde ShoresExecutive Officer, Director
Offering amount
$145K
Amount sold
$145K
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedAug 2020 · 17 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Tracy EllisExecutive Officer
  • Carl CasaleDirector
  • Clyde ShoresExecutive Officer, Director
  • Robert SchmidtDirector
  • Gordon AltonExecutive Officer, Director
  • David WebbDirector
Offering amount
$7.5M
Amount sold
$2.1M
First sale
Aug 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

OrigeneOriGene develops and manufactures research and diagnostic products, including large-scale GMP antibody production, with R&D and research manufacturing operations. It serves the life sciences and biotech research market from facilities in the US and Germany.
NeurogeneNeurogene develops gene therapy treatments for rare neurological diseases. The company aims to make severe genetic neurological conditions treatable for patients and families impacted by these conditions.
Seegene Venture CapitalSeegene is a molecular diagnostics company; this page is its investor relations section listing quarterly earnings release IR books available for download.

Companies working in the same space as Agragene.

In the news

Agragene announces another funding round after relocation to St. Louisagragene.com · Mar 2023Agragene Raises $1.2 Million in Seed Round Financing From Ospraie Ag Science - BioSpacebiospace.com · Mar 2020

Frequently asked questions

What does Agragene do?
Agragene develops Precision-Guided Sterile Insect Technology (pgSIT) marketed as KNOCKOUT™, a biocontrol product for controlling crop insect pests such as Spotted Wing Drosophila while reducing reliance on traditional insecticides. It serves agricultural growers of berries and cherries in the US and Canada, working alongside integrated pest management programs.
Who are Agragene's investors?
Agragene's investors include Missouri Technology Corporation, Ospraie Ag Science, BioGenerator Ventures.
How much funding has Agragene raised?
Agragene has disclosed $3.4M raised across 3 of its 5 known rounds.
Where is Agragene headquartered?
Agragene is headquartered in San Diego, US.